First Alzheimer’s Drug in 20 Years Now at DENT

First Alzheimer's Drug

First Alzheimer’s Drug in 20 Years DENT Patients Who Qualify Will Undergo Meticulous Screening By Annette Pinder Aducanumab is the first FDA-approved therapy for Alzheimer’s disease in 20 years, and DENT Neurologic Institute (DENT) is one of the first to administer it. However, eligibility to receive the

Read more

Celebrating 2000th TAVR Procedure

Gates Vascular Institute (GVI) Celebrates Landmark 2000th Transcatheter Heart Valve Procedure (TAVR) TAVR is a minimally invasive treatment option that has revolutionized cardiac medicine and replaced open-heart surgery for many patients Buffalo, N.Y (March 11, 2021) – The structural heart team at Kaleida Health’s Gates Vascular Institute (GVI)

Read more

UB Behavioral Health Clinic

New clinic will harness NIH-funded addictions research expertise of UB Social Work scientists Behavioral Health Clinic will provide outpatient research-based treatment to eligible community members BUFFALO, N.Y. — The University at Buffalo School of Social Work is embarking on a new strategic focus on translational research with

Read more

Secondhand Smoke Exposure Linked to Adverse Pregnancy Outcomes

Roswell Park/University at Buffalo study finds significant risk for women who never smoked BUFFALO, N.Y. — Secondhand smoking is linked with pregnancy loss, including miscarriage, stillbirth and tubal ectopic pregnancy, according to new research from scientists at Roswell Park Cancer Institute (RPCI) and the University at Buffalo

Read more